The dawn of precision medicine in diffuse-type gastric cancer

A Ooki, K Yamaguchi - Therapeutic Advances in Medical …, 2022 - journals.sagepub.com
Gastric cancer (GC) is one of the most common malignancies worldwide. The histology-and
morphology-based Lauren classification of GC has been widely used for over 50 years in …

Perioperative treatment in resectable gastric cancer: current perspectives and future directions

A Petrillo, L Pompella, G Tirino, A Pappalardo… - Cancers, 2019 - mdpi.com
Gastric cancer (GC) is the fifth-most common cancer worldwide and an important cause of
cancer-related-death. The growing knowledge of its molecular pathogenesis has shown that …

The Italian Research Group for Gastric Cancer (GIRCG) guidelines for gastric cancer staging and treatment: 2015

G De Manzoni, D Marrelli, GL Baiocchi, P Morgagni… - Gastric Cancer, 2017 - Springer
The Italian Research Group for Gastric Cancer (GIRCG) guidelines for gastric cancer
staging and treatment: 2015 | SpringerLink Skip to main content Advertisement …

Prognostic significance of frequent CLDN18-ARHGAP26/6 fusion in gastric signet-ring cell cancer

Y Shu, W Zhang, Q Hou, L Zhao, S Zhang… - Nature …, 2018 - nature.com
Signet-ring cell carcinoma (SRCC) has specific epidemiology and oncogenesis in gastric
cancer, however, with no systematical investigation for prognostic genomic features. Here …

International comparison of the German evidence-based S3-guidelines on the diagnosis and multimodal treatment of early and locally advanced gastric cancer …

M Moehler, CTH Baltin, M Ebert, W Fischbach, I Gockel… - Gastric Cancer, 2015 - Springer
Background Clinical guidelines are essential in implementing and maintaining nationwide
stage-specific diagnostic and therapeutic standards. In 2011, the first German expert …

Histological and mutational profile of diffuse gastric cancer: current knowledge and future challenges

J Garcia‐Pelaez, R Barbosa‐Matos, I Gullo… - Molecular …, 2021 - Wiley Online Library
Gastric cancer (GC) pathogenesis is complex and heterogeneous, reflecting morphological,
molecular and genetic diversity. Diffuse gastric cancer (DGC) and intestinal gastric cancer …

Is signet-ring cell carcinoma a specific entity among gastric cancers?

T Voron, M Messager, A Duhamel, J Lefevre, JY Mabrut… - Gastric Cancer, 2016 - Springer
Background The prognosis and chemoresistance of signet-ring cell (SRC) gastric
adenocarcinoma have been reported and debated, and the utility of perioperative …

[HTML][HTML] Tumor response evaluation after neoadjuvant chemotherapy in locally advanced gastric adenocarcinoma: a prospective, multi-center cohort study

P Achilli, P De Martini, M Ceresoli, GM Mari… - Journal of …, 2017 - ncbi.nlm.nih.gov
Background To verify the prognostic value of the pathologic and radiological tumor response
after neoadjuvant chemotherapy in the treatment of locally advanced gastric …

Controversies in the treatment of local and locally advanced gastric and esophageal cancers

DJ Cohen, L Leichman - Journal of Clinical Oncology, 2015 - ascopubs.org
Despite overall progress in the therapy of local and locally advanced esophageal,
gastroesophageal junction, and gastric adenocarcinomas, death as a result of these tumors …

Gastric signet ring cell carcinoma: current management and future challenges

Y Li, Z Zhu, F Ma, L Xue, Y Tian - Cancer Management and …, 2020 - Taylor & Francis
Recent advances in the epidemiology, pathology, molecular mechanisms, and combined
modality therapy (CMT) fields have shown that gastric signet ring cell carcinoma (GSRC) …